Skip to main content
. 2022 Jul 25;16:933401. doi: 10.3389/fnhum.2022.933401

TABLE 2.

Delayed-match-to-sample – delayed recognition (DMS-DR) performance by TBI status.

#Subjects Positive stim NoStim Negative stim %Change positive stim %Change negative stim
ALL STIM
Control 11 81.1% ± 3.8% 70.6% ± 4.1% 71.9% ± 5.4% 14.8% 1.8%
RMBI 7 75.4% ± 7.2% 65.1% ± 8.3% 61.8% ± 11.6% 15.8% –5.0%
TBI 7 80.5% ± 3.1% 70.6% ± 7.9% 60.2% ± 7.8% 14.1% –14.8%
MDM STIM
Control 10 79.9% ± 3.7% 70.2% ± 4.9% 71.7% ± 5.5% 13.8% 2.2%
RMBI 5 79.1% ± 9.3% 70.2% ± 9.5% 71.7% ± 9.4% 12.7% 2.2%
TBI 4 78.6% ± 3.2% 61.8% ± 9.7% 58.5% ± 7.6% 27.3% –5.4%
MIMO STIM
CONTROL 4 89.7% ± 3.9% 66.0% ± 6.5% 67.5% ± 8.5% 36.0% 2.4%
RMBI 2 65.9% ± 10.0% 52.3% ± 17.9% 12.5% ± .0% 26.1% –76.1%
TBI 5 80.8% ± 4.1% 73.6% ± 9.2% 59.8% ± 11.0% 9.8% –18.8%

Stimulated and non-stimulated task performance by TBI Status for subjects receiving CA1 stimulation based on MDM and MIMO models. Positive stim = stimulation patterns derived from modeling correct DMS trials (MIMO) or from MDM patterns that were congruent with the content classification of the Sample/Match image. NoStim = trials with no stimulation delivered. Negative stim = trials with random stimulation patterns (MIMO) or from MDM that were not specific to the content classification of the Sample/Match image). Stimulation was only delivered during the Sample phase of DMS trials, and not delivered during Match phase, nor during the DR assessment. %Change = percentage of increase (+, no symbol) or decrease (–) compared to NoStim.